Global CRISPR Gene Testing and Diagnostics Market Research Report 2025(Status and Outlook)

Report Overview

CRISPR gene testing and diagnostics leverage the precision of CRISPR-Cas9 and related gene-editing technologies to identify, analyze, and sometimes modify genetic sequences associated with diseases, hereditary conditions, or other biological traits. This market encompasses a range of applications, including early disease detection, personalized medicine, carrier screening, and even agricultural biotechnology. The technology's ability to target specific DNA sequences with high accuracy has revolutionized genetic diagnostics by offering faster, cheaper, and more scalable solutions compared to traditional PCR or sequencing methods. Key players include biotech firms, diagnostic laboratories, and pharmaceutical companies developing CRISPR-based tools for both clinical and research use. The market is driven by rising demand for precision medicine, increasing investments in genomic research, and growing awareness of genetic disorders, though regulatory hurdles and ethical concerns remain significant challenges.

The global CRISPR Gene Testing and Diagnostics market size was estimated at USD 1255.0 million in 2024, exhibiting a CAGR of 25.50% during the forecast period.

This report provides a deep insight into the global CRISPR Gene Testing and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CRISPR Gene Testing and Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CRISPR Gene Testing and Diagnostics market in any manner.

Global CRISPR Gene Testing and Diagnostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

10x Genomics

Aelian Biotechnology

Agilent Technologies

Axxam

Beckman Coulter

Becton

Dickinson and Company

Binx Health

bioMérieux

Bio-Rad Laboratories

Caspr Biotech

ERS Genomics

FASMAC

Illumina

Janssen Diagnostics

Locus Biosciences

Mammoth Biosciences

NRGene

Roche

Sherlock Biosciences

Thermo Fisher Scientific

Vivlion

Market Segmentation (by Type)

Animals

Plants

Pathogens

Others

Market Segmentation (by Application)

Medical Industry

Agriculture

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the CRISPR Gene Testing and Diagnostics Market

Overview of the regional outlook of the CRISPR Gene Testing and Diagnostics Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CRISPR Gene Testing and Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of CRISPR Gene Testing and Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of CRISPR Gene Testing and Diagnostics
1.2 Key Market Segments
1.2.1 CRISPR Gene Testing and Diagnostics Segment by Type
1.2.2 CRISPR Gene Testing and Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CRISPR Gene Testing and Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global CRISPR Gene Testing and Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global CRISPR Gene Testing and Diagnostics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CRISPR Gene Testing and Diagnostics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global CRISPR Gene Testing and Diagnostics Product Life Cycle
3.3 Global CRISPR Gene Testing and Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 CRISPR Gene Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CRISPR Gene Testing and Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 CRISPR Gene Testing and Diagnostics Market Competitive Situation and Trends
3.8.1 CRISPR Gene Testing and Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest CRISPR Gene Testing and Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CRISPR Gene Testing and Diagnostics Industry Chain Analysis
4.1 CRISPR Gene Testing and Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of CRISPR Gene Testing and Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CRISPR Gene Testing and Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to CRISPR Gene Testing and Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 CRISPR Gene Testing and Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CRISPR Gene Testing and Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global CRISPR Gene Testing and Diagnostics Market Size Market Share by Type (2020-2025)
6.4 Global CRISPR Gene Testing and Diagnostics Price by Type (2020-2025)
7 CRISPR Gene Testing and Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CRISPR Gene Testing and Diagnostics Market Sales by Application (2020-2025)
7.3 Global CRISPR Gene Testing and Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global CRISPR Gene Testing and Diagnostics Sales Growth Rate by Application (2020-2025)
8 CRISPR Gene Testing and Diagnostics Market Sales by Region
8.1 Global CRISPR Gene Testing and Diagnostics Sales by Region
8.1.1 Global CRISPR Gene Testing and Diagnostics Sales by Region
8.1.2 Global CRISPR Gene Testing and Diagnostics Sales Market Share by Region
8.2 Global CRISPR Gene Testing and Diagnostics Market Size by Region
8.2.1 Global CRISPR Gene Testing and Diagnostics Market Size by Region
8.2.2 Global CRISPR Gene Testing and Diagnostics Market Size Market Share by Region
8.3 North America
8.3.1 North America CRISPR Gene Testing and Diagnostics Sales by Country
8.3.2 North America CRISPR Gene Testing and Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CRISPR Gene Testing and Diagnostics Sales by Country
8.4.2 Europe CRISPR Gene Testing and Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CRISPR Gene Testing and Diagnostics Sales by Region
8.5.2 Asia Pacific CRISPR Gene Testing and Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CRISPR Gene Testing and Diagnostics Sales by Country
8.6.2 South America CRISPR Gene Testing and Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CRISPR Gene Testing and Diagnostics Sales by Region
8.7.2 Middle East and Africa CRISPR Gene Testing and Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CRISPR Gene Testing and Diagnostics Market Production by Region
9.1 Global Production of CRISPR Gene Testing and Diagnostics by Region(2020-2025)
9.2 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global CRISPR Gene Testing and Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CRISPR Gene Testing and Diagnostics Production
9.4.1 North America CRISPR Gene Testing and Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America CRISPR Gene Testing and Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CRISPR Gene Testing and Diagnostics Production
9.5.1 Europe CRISPR Gene Testing and Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe CRISPR Gene Testing and Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CRISPR Gene Testing and Diagnostics Production (2020-2025)
9.6.1 Japan CRISPR Gene Testing and Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan CRISPR Gene Testing and Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CRISPR Gene Testing and Diagnostics Production (2020-2025)
9.7.1 China CRISPR Gene Testing and Diagnostics Production Growth Rate (2020-2025)
9.7.2 China CRISPR Gene Testing and Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 10x Genomics
10.1.1 10x Genomics Basic Information
10.1.2 10x Genomics CRISPR Gene Testing and Diagnostics Product Overview
10.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Product Market Performance
10.1.4 10x Genomics Business Overview
10.1.5 10x Genomics SWOT Analysis
10.1.6 10x Genomics Recent Developments
10.2 Aelian Biotechnology
10.2.1 Aelian Biotechnology Basic Information
10.2.2 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product Overview
10.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product Market Performance
10.2.4 Aelian Biotechnology Business Overview
10.2.5 Aelian Biotechnology SWOT Analysis
10.2.6 Aelian Biotechnology Recent Developments
10.3 Agilent Technologies
10.3.1 Agilent Technologies Basic Information
10.3.2 Agilent Technologies CRISPR Gene Testing and Diagnostics Product Overview
10.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Product Market Performance
10.3.4 Agilent Technologies Business Overview
10.3.5 Agilent Technologies SWOT Analysis
10.3.6 Agilent Technologies Recent Developments
10.4 Axxam
10.4.1 Axxam Basic Information
10.4.2 Axxam CRISPR Gene Testing and Diagnostics Product Overview
10.4.3 Axxam CRISPR Gene Testing and Diagnostics Product Market Performance
10.4.4 Axxam Business Overview
10.4.5 Axxam Recent Developments
10.5 Beckman Coulter
10.5.1 Beckman Coulter Basic Information
10.5.2 Beckman Coulter CRISPR Gene Testing and Diagnostics Product Overview
10.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Product Market Performance
10.5.4 Beckman Coulter Business Overview
10.5.5 Beckman Coulter Recent Developments
10.6 Becton
10.6.1 Becton Basic Information
10.6.2 Becton CRISPR Gene Testing and Diagnostics Product Overview
10.6.3 Becton CRISPR Gene Testing and Diagnostics Product Market Performance
10.6.4 Becton Business Overview
10.6.5 Becton Recent Developments
10.7 Dickinson and Company
10.7.1 Dickinson and Company Basic Information
10.7.2 Dickinson and Company CRISPR Gene Testing and Diagnostics Product Overview
10.7.3 Dickinson and Company CRISPR Gene Testing and Diagnostics Product Market Performance
10.7.4 Dickinson and Company Business Overview
10.7.5 Dickinson and Company Recent Developments
10.8 Binx Health
10.8.1 Binx Health Basic Information
10.8.2 Binx Health CRISPR Gene Testing and Diagnostics Product Overview
10.8.3 Binx Health CRISPR Gene Testing and Diagnostics Product Market Performance
10.8.4 Binx Health Business Overview
10.8.5 Binx Health Recent Developments
10.9 bioMérieux
10.9.1 bioMérieux Basic Information
10.9.2 bioMérieux CRISPR Gene Testing and Diagnostics Product Overview
10.9.3 bioMérieux CRISPR Gene Testing and Diagnostics Product Market Performance
10.9.4 bioMérieux Business Overview
10.9.5 bioMérieux Recent Developments
10.10 Bio-Rad Laboratories
10.10.1 Bio-Rad Laboratories Basic Information
10.10.2 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product Overview
10.10.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product Market Performance
10.10.4 Bio-Rad Laboratories Business Overview
10.10.5 Bio-Rad Laboratories Recent Developments
10.11 Caspr Biotech
10.11.1 Caspr Biotech Basic Information
10.11.2 Caspr Biotech CRISPR Gene Testing and Diagnostics Product Overview
10.11.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Product Market Performance
10.11.4 Caspr Biotech Business Overview
10.11.5 Caspr Biotech Recent Developments
10.12 ERS Genomics
10.12.1 ERS Genomics Basic Information
10.12.2 ERS Genomics CRISPR Gene Testing and Diagnostics Product Overview
10.12.3 ERS Genomics CRISPR Gene Testing and Diagnostics Product Market Performance
10.12.4 ERS Genomics Business Overview
10.12.5 ERS Genomics Recent Developments
10.13 FASMAC
10.13.1 FASMAC Basic Information
10.13.2 FASMAC CRISPR Gene Testing and Diagnostics Product Overview
10.13.3 FASMAC CRISPR Gene Testing and Diagnostics Product Market Performance
10.13.4 FASMAC Business Overview
10.13.5 FASMAC Recent Developments
10.14 Illumina
10.14.1 Illumina Basic Information
10.14.2 Illumina CRISPR Gene Testing and Diagnostics Product Overview
10.14.3 Illumina CRISPR Gene Testing and Diagnostics Product Market Performance
10.14.4 Illumina Business Overview
10.14.5 Illumina Recent Developments
10.15 Janssen Diagnostics
10.15.1 Janssen Diagnostics Basic Information
10.15.2 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product Overview
10.15.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product Market Performance
10.15.4 Janssen Diagnostics Business Overview
10.15.5 Janssen Diagnostics Recent Developments
10.16 Locus Biosciences
10.16.1 Locus Biosciences Basic Information
10.16.2 Locus Biosciences CRISPR Gene Testing and Diagnostics Product Overview
10.16.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Product Market Performance
10.16.4 Locus Biosciences Business Overview
10.16.5 Locus Biosciences Recent Developments
10.17 Mammoth Biosciences
10.17.1 Mammoth Biosciences Basic Information
10.17.2 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product Overview
10.17.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product Market Performance
10.17.4 Mammoth Biosciences Business Overview
10.17.5 Mammoth Biosciences Recent Developments
10.18 NRGene
10.18.1 NRGene Basic Information
10.18.2 NRGene CRISPR Gene Testing and Diagnostics Product Overview
10.18.3 NRGene CRISPR Gene Testing and Diagnostics Product Market Performance
10.18.4 NRGene Business Overview
10.18.5 NRGene Recent Developments
10.19 Roche
10.19.1 Roche Basic Information
10.19.2 Roche CRISPR Gene Testing and Diagnostics Product Overview
10.19.3 Roche CRISPR Gene Testing and Diagnostics Product Market Performance
10.19.4 Roche Business Overview
10.19.5 Roche Recent Developments
10.20 Sherlock Biosciences
10.20.1 Sherlock Biosciences Basic Information
10.20.2 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product Overview
10.20.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product Market Performance
10.20.4 Sherlock Biosciences Business Overview
10.20.5 Sherlock Biosciences Recent Developments
10.21 Thermo Fisher Scientific
10.21.1 Thermo Fisher Scientific Basic Information
10.21.2 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product Overview
10.21.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product Market Performance
10.21.4 Thermo Fisher Scientific Business Overview
10.21.5 Thermo Fisher Scientific Recent Developments
10.22 Vivlion
10.22.1 Vivlion Basic Information
10.22.2 Vivlion CRISPR Gene Testing and Diagnostics Product Overview
10.22.3 Vivlion CRISPR Gene Testing and Diagnostics Product Market Performance
10.22.4 Vivlion Business Overview
10.22.5 Vivlion Recent Developments
11 CRISPR Gene Testing and Diagnostics Market Forecast by Region
11.1 Global CRISPR Gene Testing and Diagnostics Market Size Forecast
11.2 Global CRISPR Gene Testing and Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CRISPR Gene Testing and Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific CRISPR Gene Testing and Diagnostics Market Size Forecast by Region
11.2.4 South America CRISPR Gene Testing and Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CRISPR Gene Testing and Diagnostics by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global CRISPR Gene Testing and Diagnostics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of CRISPR Gene Testing and Diagnostics by Type (2026-2033)
12.1.2 Global CRISPR Gene Testing and Diagnostics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of CRISPR Gene Testing and Diagnostics by Type (2026-2033)
12.2 Global CRISPR Gene Testing and Diagnostics Market Forecast by Application (2026-2033)
12.2.1 Global CRISPR Gene Testing and Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global CRISPR Gene Testing and Diagnostics Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings